AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ २९.६८
arrow_downward
-०.७०%(-०.२१) 1D
US$ २९.६८
०.००% (०.००)
bedtimeAfter hours
Closed: नोभेम्बर १८, १६:००:०१ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$ २९.५७
High
US$ ३०.४८
Low
US$ २९.२२
Mkt. cap
१.७८ अरब
Avg. vol.
१२.१३ लाख
Volume
६.०० लाख
52-wk high
US$ ४४.०७
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
Open
US$ २९.५७
High
US$ ३०.४८
Low
US$ २९.२२
Mkt. cap
१.७८ अरब
Avg. vol.
१२.१३ लाख
Volume
६.०० लाख
52-wk high
US$ ४४.०७
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
News stories
From web sources and news partners
FXStreet
·
२४ मिनेट पहिले
Dow Jones Industrial Average drops as UnitedHealth and Nvidia fall
BeInCrypto
·
१ घण्टा पहिले
S&P 500 Breaks Critical Support: Is a Bigger Stock Market Crash Coming?
TV News Check
·
१ घण्टा पहिले
Dow Drops 561, Nasdaq Rises 102, S&P 500 Loses 17
Traders Union
·
५३ मिनेट पहिले
Peter Tuchman: S&P 500 loses $2.5 trillion in market cap over five days
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc